Medical device managers rely on physicians to screen out defects rather than issue recalls
By a
The study also found that some managers appear to hesitate to recall a product until the root cause of the defect is clearly understood, because this can reduce recall costs to the firm.
The study, performed by professors at the
Their research, published in the
"The decision to recall a product can significantly affect an operations manager's career, the credibility and financial performance of the firm, and the safety of customers," the authors wrote. "Surprisingly, the FDA does not clearly specify how a manager should integrate the multiple, and potentially conflicting, criteria influencing whether or not to recall a product. Consequently, managers use individual judgment in arriving at recall decisions."
A key finding of the study is that "medical device industry managers appear to trust physicians to screen out defects on behalf of the firm, meaning that when the defect is detectable to the physician, managers are less likely to recall," Ball said. "This is because of a perception of increased patient safety when defects are detectable."
Ball and his colleagues --
After working closely with these managers, Shah said they observed that, "most of these managers are very technically oriented, and they want to know 'why' before they take an action that could be very costly both in direct financial consequences and in reputational harm. Waiting to understand root cause before choosing to recall, however, is not required by the FDA."
The researchers also found a relationship between a manager's cognition and their recall decision. In particular, managers with high cognitive reflection issued fewer recalls. The ability to first reflect, before making a quick, intuitive decision, may lead to fewer recalls because such reflective individuals have a tendency to seek out more information before reaching a decision. Non-reflective, intuitive managers, conversely, were influenced by relational factors such as their gender, work experience and perception of their firm's relationship with the FDA.
While the paper focuses on operations at medical device manufacturers, the authors believe that the findings have broader applications. "Any industry in which the supply chain has multiple stages where quality can be observed and controlled may be susceptible to the study's conclusions," said Donohue. "For example, auto firms may trust their dealers to catch their mistakes before selling their cars to the final customer."
Keywords for this news article include: Medical Devices,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC


ACEC Business Insurance Trust Announces Leadership Changes and New Trustee Appointments
Advisor News
- Wealth planning vs. estate planning: Honoring your client’s wishes
- What to discuss during the first retirement planning meeting
- Inflation, competing priorities and uncertainty erode retirement security
- As health premiums rise, 1 in 8 workers cut retirement savings
- CT governor’s candidates claims: What’s true, and what’s misleading
More Advisor NewsAnnuity News
- National Life Group expands annuity portfolio
- AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
- USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
- How flexible annuities fit today’s retirement portfolios
- Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity NewsHealth/Employee Benefits News
- How the law protecting Americans from surprise medical bills is driving up healthcare costs
- Medicare Plus supplement vs. Medicare Advantage (Maybe) 2026– Healthful Hints
- ‘Medically frail’ Medicaid enrollees won’t have to prove their inability to work to keep coverage
- IMPLEMENTATION OF IMMIGRANT ELIGIBILITY RESTRICTIONS FOR ACA MARKETPLACE SUBSIDIES UNDER THE 2025 RECONCILIATION LAW: ISSUES TO CONSIDER
- ACA HEALTH INSURANCE RATES RELEASED FOR 2027 OPEN ENROLLMENT
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Insignia Life S.A. de C.V.
- FINANCIAL FRAUD
- Security Benefit Announces Planned Dividend Rate Reset for Series B Preferred Stock
- Palmetto Heritage and Atlantic Coast Life Announce Discussions Regarding Potential Acquisition
- Jury finds insurance company acted in bad faith, awards Nebraska woman $11.3M
More Life Insurance News